1. Home
  2. PRPL vs DBVT Comparison

PRPL vs DBVT Comparison

Compare PRPL & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPL
  • DBVT
  • Stock Information
  • Founded
  • PRPL 2010
  • DBVT 2002
  • Country
  • PRPL United States
  • DBVT France
  • Employees
  • PRPL N/A
  • DBVT N/A
  • Industry
  • PRPL Home Furnishings
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PRPL Consumer Discretionary
  • DBVT Health Care
  • Exchange
  • PRPL Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • PRPL 96.8M
  • DBVT 102.0M
  • IPO Year
  • PRPL N/A
  • DBVT N/A
  • Fundamental
  • Price
  • PRPL $0.56
  • DBVT $7.98
  • Analyst Decision
  • PRPL Hold
  • DBVT Strong Buy
  • Analyst Count
  • PRPL 2
  • DBVT 2
  • Target Price
  • PRPL $1.25
  • DBVT $22.50
  • AVG Volume (30 Days)
  • PRPL 390.3K
  • DBVT 1.2M
  • Earning Date
  • PRPL 05-06-2025
  • DBVT 05-06-2025
  • Dividend Yield
  • PRPL N/A
  • DBVT N/A
  • EPS Growth
  • PRPL N/A
  • DBVT N/A
  • EPS
  • PRPL N/A
  • DBVT N/A
  • Revenue
  • PRPL $487,877,000.00
  • DBVT $4,151,000.00
  • Revenue This Year
  • PRPL N/A
  • DBVT $1,679.52
  • Revenue Next Year
  • PRPL $5.62
  • DBVT $535.67
  • P/E Ratio
  • PRPL N/A
  • DBVT N/A
  • Revenue Growth
  • PRPL N/A
  • DBVT N/A
  • 52 Week Low
  • PRPL $0.60
  • DBVT $0.44
  • 52 Week High
  • PRPL $1.75
  • DBVT $8.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPL 31.67
  • DBVT 64.55
  • Support Level
  • PRPL $0.60
  • DBVT $7.00
  • Resistance Level
  • PRPL $0.69
  • DBVT $7.80
  • Average True Range (ATR)
  • PRPL 0.08
  • DBVT 0.96
  • MACD
  • PRPL -0.01
  • DBVT 0.07
  • Stochastic Oscillator
  • PRPL 1.07
  • DBVT 81.09

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: